VEGFR2/CD309 抗体 (Biotin)
Quick Overview for VEGFR2/CD309 抗体 (Biotin) (ABIN1589688)
抗原
See all VEGFR2/CD309 (VEGFR2) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
原理
- VEGFR-2/KDR antibody
-
特异性
- Recombinant human KDR (D1-7)
-
产品特性
-
Chromosomal location: 4q11-q12
Produced from sera of rabbits immunised with highly pure recombinant human soluble extracellular domain of KDR (110 kDa) as the immunizing antigen. -
纯化方法
- Anti-human VEGFR-2/KDR was purified by antigen-affinity chromatography with immobilised recombinant soluble VEGFR-2/KDR and then biotinylated using a standard protocol.
-
免疫原
- Recombinant human KDR (D1-7) (ABIN1589573)
-
亚型
- IgG
-
-
-
-
应用备注
- ELISA: Use 5-15 μg/mL
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.
-
缓冲液
- PBS, BSA (50x), 0.02 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Centrifuge vial prior to opening.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.
-
有效期
- 24 months
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
别名
- VEGFR-2/KDR
-
背景
- Vascular endothelial growth factor receptor-2 , KDR, FLK1, CD309, VEGF receptor 2, VEGFR2, kinase insert domain protein receptor,VEGF R1 (Flt-1), VEGF R2 (KDR/Flk-1), and VEGF R3 (Flt-4) belong to the class III subfamily of receptor tyrosine kinases (RTKs). All three receptors contain seven immunoglobulin-like repeats in their extracellular domain and kinase insert domains in their intracellular region. They are best known for regulating VEGF family-mediated vasculogenesis, angiogenesis, and lymphangiogenesis. They are also mediators of neurotrophic activity and regulators of hematopoietic development. Human VEGF R2 is thought to be the primary inducer of VEGF-mediated blood vessel growth, while VEGF R3 plays a significant role in VEGF-C and VEGF-D-mediated lymphangiogenesis.
-
基因ID
- 3791
-
NCBI登录号
- NM_002253, NP_002244
-
UniProt
- P35968
-
途径
- RTK signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
抗原
-